1. Home
  2. LTRN vs LRE Comparison

LTRN vs LRE Comparison

Compare LTRN & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • LRE
  • Stock Information
  • Founded
  • LTRN 2013
  • LRE 2001
  • Country
  • LTRN United States
  • LRE Japan
  • Employees
  • LTRN N/A
  • LRE 70
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • LRE
  • Sector
  • LTRN Health Care
  • LRE
  • Exchange
  • LTRN Nasdaq
  • LRE Nasdaq
  • Market Cap
  • LTRN 36.2M
  • LRE 29.9M
  • IPO Year
  • LTRN 2020
  • LRE 2023
  • Fundamental
  • Price
  • LTRN $2.99
  • LRE $2.23
  • Analyst Decision
  • LTRN Hold
  • LRE
  • Analyst Count
  • LTRN 1
  • LRE 0
  • Target Price
  • LTRN N/A
  • LRE N/A
  • AVG Volume (30 Days)
  • LTRN 50.0K
  • LRE 44.1K
  • Earning Date
  • LTRN 11-07-2024
  • LRE 01-01-0001
  • Dividend Yield
  • LTRN N/A
  • LRE N/A
  • EPS Growth
  • LTRN N/A
  • LRE N/A
  • EPS
  • LTRN N/A
  • LRE 0.29
  • Revenue
  • LTRN N/A
  • LRE $117,804,154.00
  • Revenue This Year
  • LTRN N/A
  • LRE N/A
  • Revenue Next Year
  • LTRN N/A
  • LRE N/A
  • P/E Ratio
  • LTRN N/A
  • LRE $7.30
  • Revenue Growth
  • LTRN N/A
  • LRE 8.82
  • 52 Week Low
  • LTRN $2.79
  • LRE $1.19
  • 52 Week High
  • LTRN $11.99
  • LRE $13.76
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 36.73
  • LRE 62.14
  • Support Level
  • LTRN $3.04
  • LRE $2.11
  • Resistance Level
  • LTRN $3.57
  • LRE $2.24
  • Average True Range (ATR)
  • LTRN 0.25
  • LRE 0.10
  • MACD
  • LTRN -0.05
  • LRE -0.00
  • Stochastic Oscillator
  • LTRN 14.81
  • LRE 75.86

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: